# A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer

> **NCT02667327** · PHASE3 · TERMINATED · sponsor: **Xequel Bio, Inc.** · enrollment: 124 (actual)

## Conditions studied

- Diabetic Foot Ulcers

## Interventions

- **DRUG:** Granexin gel
- **OTHER:** Vehicle gel

## Key facts

- **NCT ID:** NCT02667327
- **Lead sponsor:** Xequel Bio, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-11-21
- **Primary completion:** 2020-05-27
- **Final completion:** 2020-05-27
- **Target enrollment:** 124 (ACTUAL)
- **Why stopped:** Sponsor Decision (No safety or efficacy concerns)
- **Last updated:** 2020-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667327, "A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02667327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*